Ronan Kempf, Global Marketing and Development Lead at Agrauxine.
When it comes to R&D — coming up with the “next big thing” really depends on what opportunities you see in the marketplace. But, it’s always difficult seeing and identifying what exactly that next, big opportunity is.
With consumer demand ever-changing, it is hard to say what the “next big thing” might be. The most important step in identifying the “next big thing” in biologicals, is ensuring that growers and regulators understand biologicals. Once we can educate our audiences on biologicals, then we can identify where we go from there.